HT, M., J, H., JK, P., A, S., K, C., M, G., . . . ML, D. (2008). Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides. BMC immunology, 9, 9. https://doi.org/10.1186/1471-2172-9-9
Chicago Style (17th ed.) CitationHT, Maecker, et al. "Precision and Linearity Targets for Validation of an IFNgamma ELISPOT, Cytokine Flow Cytometry, and Tetramer Assay Using CMV Peptides." BMC Immunology 9 (2008): 9. https://doi.org/10.1186/1471-2172-9-9.
MLA (9th ed.) CitationHT, Maecker, et al. "Precision and Linearity Targets for Validation of an IFNgamma ELISPOT, Cytokine Flow Cytometry, and Tetramer Assay Using CMV Peptides." BMC Immunology, vol. 9, 2008, p. 9, https://doi.org/10.1186/1471-2172-9-9.